Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
2021
Historique:
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 19 5 2021
Statut: ppublish

Résumé

Secondary immune thrombocytopenic purpura (ITP) with non-Hodgkin lymphoma (NHL) is a rare disease. Although some treatment regimens are available for primary ITP, the treatment strategy for secondary ITP remains unconfirmed. We herein report a 79-year-old man who was diagnosed with secondary ITP with mantle cell lymphoma. Although intravenous immunoglobulin (IVIG) has been considered an effective option for secondary ITP, similar to the treatment of primary ITP, our patient did not benefit from IVIG. A literature review including the current report revealed that IVIG was ineffective in all treated patients. Secondary ITP with NHL should be treated differently from primary ITP.

Identifiants

pubmed: 33994446
doi: 10.2169/internalmedicine.5611-20
pmc: PMC8188037
doi:

Substances chimiques

Immunoglobulins, Intravenous 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1583-1588

Références

Blood. 2008 Jan 15;111(2):715-22
pubmed: 17932250
Eur J Haematol. 2020 Mar;104(3):259-270
pubmed: 31840311
Ann Hematol. 2014 Feb;93(2):353-4
pubmed: 23743539
Mol Clin Oncol. 2019 Apr;10(4):441-445
pubmed: 30931114
Case Rep Dermatol. 2014 Feb 12;6(1):37-42
pubmed: 24707248
Mol Clin Oncol. 2017 Nov;7(5):855-858
pubmed: 29181179
N Engl J Med. 1986 May 8;314(19):1236-9
pubmed: 2939345
Blood. 2009 Jun 25;113(26):6511-21
pubmed: 19395674
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6386-90
pubmed: 25337296
Intern Med. 2011;50(11):1215-8
pubmed: 21628938
Hematol Oncol. 2013 Dec;31(4):218-20
pubmed: 23606442
J Immunol. 2007 Oct 15;179(8):5571-5
pubmed: 17911644
Intern Med. 2018 Sep 1;57(17):2573-2579
pubmed: 29607959
Ann Thorac Surg. 2009 Oct;88(4):e37-8
pubmed: 19766775
Nature. 2011 Jun 19;475(7354):110-3
pubmed: 21685887
Haematologica. 2008 Mar;93(3):447-50
pubmed: 18287133
Cancer Res Treat. 2012 Mar;44(1):69-72
pubmed: 22500164
Blood. 1996 May 15;87(10):4245-54
pubmed: 8639783
Br J Haematol. 2012 Jan;156(1):145-7
pubmed: 21848881
Intern Med. 2016;55(20):2951-2956
pubmed: 27746431
Surg Neurol Int. 2010 Nov 27;1:76
pubmed: 21170367
N Engl J Med. 1982 May 27;306(21):1254-8
pubmed: 6803159
Cytokine. 2019 Aug;120:234-241
pubmed: 31129375

Auteurs

Yuya Kurihara (Y)

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.

Kazuki Taoka (K)

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.

Eri Takagi (E)

General Education Center, The University of Tokyo Hospital, Japan.

Kazuhiro Toyama (K)

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.

Kumi Nakazaki (K)

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.

Mineo Kurokawa (M)

Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH